Cardiovascular risk and respiratory disease: the influence of diet

Raphaëlle Varraso (Villejuif, France)

Source: International Congress 2015 – Nutrition in chronic respiratory disease
Session: Nutrition in chronic respiratory disease
Session type: Symposium
Number: 1946
Disease area: Airway diseases

WebcastSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Raphaëlle Varraso (Villejuif, France). Cardiovascular risk and respiratory disease: the influence of diet. International Congress 2015 – Nutrition in chronic respiratory disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Chronic asthma and the risk of cardiovascular disease
Source: Eur Respir Monogr 2020; 88: 82-95
Year: 2020


Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

Cardiovascular risk detection in COPD
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

Cardiovascular risk and exercise capacity in COPD
Source: International Congress 2018 – Additional latest insights in pulmonary rehabilitation for chronic lung diseases
Year: 2018



The association of respiratory health and cardiovascular risk with structural brain disease in patients with COPD
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018

Global cardiovascular disease risk in U.S. adults by severity and presence of COPD
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010


Cardiovascular risk factors in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 624s
Year: 2006

Modifiable risk factors for all-cause hospitalization in obstructive lung disease
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015

Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk?
Source: Eur Respir J 2015; 46: 846-849
Year: 2015


Global cardiovascular disease risk score among U.S. adults with asthma
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010

Management of patients with asthma or COPD and cardiovascular disease: risks versus benefits
Source: Eur Respir Monogr 2020; 88: 66-81
Year: 2020


Comorbidity: a distinctive feature of elderly respiratory patients
Source: Eur Respir Mon; 2009: 43: 205–216
Year: 2009

Cardiovascular disease in COPD
Source: Eur Respir Monogr 2020; 88: 47-65
Year: 2020


Risk factors contributing to mortality in patients with COPD developing acute respiratory failure
Source: Eur Respir J 2007; 30: Suppl. 51, 557s
Year: 2007

Dietary fat in respiratory diseases: A multi-case control study
Source: International Congress 2016 – Asthma, COPD, and ACOS: physical activity, dietary aspects, and diseases burden
Year: 2016

Socioeconomic risk factors for COPD and respiratory symptoms in a general population
Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Year: 2007



Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD
Source: Eur Respir J 2008; 32: 962-969
Year: 2008



Smoking risk in cardiovascular and cerebrovascular diseases
Source: International Congress 2016 – Smoking-related diseases
Year: 2016